Founded by leading cardiovascular scientists, our team has the tenacity to pursue our ultimate peak – changing the treatment paradigm for heart disease, and in doing so improving and extending the lives of millions of individuals and families fighting this debilitating disease.
We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease.
We are revolutionizing the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.
California Institute for Regenerative Medicine - Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
The governing Board of the California Institute for Regenerative Medicine (CIRM) announced grant funding to projects in early stage or discovery research, including a $1.2 million award to Tenaya for its gene therapy program targeting heart failure due to prior myocardial infarction. Read MoreRead More
Endpoints - Manufacturing roundup: Tenaya Therapeutics completes buildout of Bay Area genetic medicine manufacturing site
Tyler Patchen of Endpoints reports on Tenaya’s new manufacturing facility, which launched operations in June of 2022. Read MoreRead More
Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics
Facility to Provide Clinical Supply of Lead Gene Therapy Programs TN-201 and TN-401 for Planned First-in-Human Studies 94,000 sq. ft. Modular Facility has Initial Production Capacity at the 1000L Scale SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 16, 2022-- Tenaya Therapeutics, Inc.Read More
JOIN OUR TEAM
Are you ambitious, driven, energized by scientific innovation and committed to making a difference for patients suffering from heart disease? Do you value a culture grounded in science and collaboration? Our team combines deep biological insights, sophisticated drug development technologies and a boundless determination to change the future for the millions of people affected by heart disease.